Related Experiment Video
Updated: Aug 19, 2026

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
[Combination of intermittent cyclical etidronate and hormone replacement therapy for postmenopausal osteoporosis]
1Department of Obstetrics and Gynecology, Tokyo Women's Medical University.
Abstract:
Treatment with etidronate alone is unlikely to increase the bone mineral density of the femoral neck. In combination of etidronate and hormone replacement therapy has been shown to markedly increase the bone mineral density of the femur and may decrease the risk of fracture. These findings suggest that etidronate and hormone replacement therapy inhibit bone resorption by different mechanisms of action. Treatment with a combination of etidronate and hormone replacement therapy may therefore be an important option for the management of postmenopausal osteoporosis.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Intrauterine Drug Delivery Systems
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
